Evaluation of Tc-99m Sestamibi residual in Becton Dickinson syringes and optimizing the configuration for dispensing.
Conclusions: As a result of this study, Northwestern Medicine has changed its standard practice. Rest Tc-99m sestamibi doses are now drawn up in 3cc syringes QS’d to 1.0mL. Stress Tc-99m sestamibi doses will continue to be drawn up in 3cc syringes QS’d to 1.5mL since this configuration resulted in the least amount of residual activity.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Schaaf, C., Houston, T., McKay, B., Riehle, L., Dillehay, G. Tags: TS27: Student Tech Papers III Source Type: research
More News: Nuclear Medicine | Perfusion | SPECT | Students | Study | Universities & Medical Training